论文部分内容阅读
目的:注射用脂溶性维生素II在上呼吸道感染疾病中的顺应性考察。方法:回顾性分析我院2012年12月—2013年10月在本院门诊就诊的急性上呼吸道感染患者的临床资料,随机分为对照组和观察组,对照组在给予正常药物及对症治疗的基础上,加用丰原林注射用脂溶性维生素(II)1支溶于100ml 5%葡萄糖或0.9%氯化钠中静脉滴注,每日一次。观察组在给予正常药物及对症治疗的基础上,加用丰原林注射用脂溶性维生素(II)1支溶于500ml 5%葡萄糖或0.9%氯化钠中静脉滴注,每日一次。结果:两组患者在接受治疗之后,大多数患者症状、体征都有所好转,观察组在好转速度上要慢于对照组,对照组的治疗效果明显较好(P<0.05)。在治疗过程中观察组有31位患者中断使用注射用脂溶性维生素II,主要原因是药液较多,输注时间较长,患者在后续的治疗中不愿使用。结论:注射用脂溶性维生素II对上呼吸道感染起着重要的辅助治疗作用,但因使用方法的不同会影响其辅助治疗的效果。
OBJECTIVE: To investigate the compliance of fat-soluble vitamin II for injection in upper respiratory tract infections. Methods: The clinical data of acute upper respiratory tract infection in our hospital from December 2012 to October 2013 in our hospital were retrospectively analyzed. They were randomly divided into control group and observation group. The control group was given normal drugs and symptomatic treatment On the basis of the addition of 1 capsule of fat-soluble vitamin (II) for injection of Fengyuan Linnaeus in 100 ml of 5% dextrose or 0.9% sodium chloride, once daily. The observation group was given normal drugs and symptomatic treatment, based on the addition of Fengyuan Linnaeus injection of fat-soluble vitamins (II) a dissolved in 500ml 5% glucose or 0.9% sodium chloride intravenously once daily. Results: After treatment, the symptoms and signs of most of the patients improved. The observation group was slower than the control group in the improvement of speed, and the treatment effect of the control group was significantly better (P <0.05). In the course of treatment, 31 patients discontinued the use of fat-soluble vitamin II for injection in the observation group, mainly due to the large number of fluids and longer infusion times, which the patients were reluctant to use in subsequent treatment. Conclusion: Lipid-soluble vitamin II for injection plays an important role in adjuvant treatment of upper respiratory tract infections. However, the effect of adjuvant therapy may be affected by different methods of use.